These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

563 related articles for article (PubMed ID: 26865062)

  • 1. Strain-transcending immune response generated by chimeras of the malaria vaccine candidate merozoite surface protein 2.
    Krishnarjuna B; Andrew D; MacRaild CA; Morales RA; Beeson JG; Anders RF; Richards JS; Norton RS
    Sci Rep; 2016 Feb; 6():20613. PubMed ID: 26865062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
    Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW
    Malar J; 2016 Mar; 15():159. PubMed ID: 26975721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and Characterisation of a Key Epitope in the Conserved C-Terminal Domain of the Malaria Vaccine Candidate MSP2.
    Seow J; Morales RA; MacRaild CA; Krishnarjuna B; McGowan S; Dingjan T; Jaipuria G; Rouet R; Wilde KL; Atreya HS; Richards JS; Anders RF; Christ D; Drinkwater N; Norton RS
    J Mol Biol; 2017 Mar; 429(6):836-846. PubMed ID: 28189425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strain-specific humoral response to a polymorphic malaria vaccine.
    Flück C; Smith T; Beck HP; Irion A; Betuela I; Alpers MP; Anders R; Saul A; Genton B; Felger I
    Infect Immun; 2004 Nov; 72(11):6300-5. PubMed ID: 15501757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of dimorphic and C-terminal fragments of Plasmodium falciparum MSP2 formulated with different adjuvants in mice.
    Balam S; Jafarshad A; Servis C; Frank G; Reed S; Pink R; Druilhe P; Spertini F; Corradin G
    Vaccine; 2016 Mar; 34(13):1566-1574. PubMed ID: 26874325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposome engraftment and antigen combination potentiate the immune response towards conserved epitopes of the malaria vaccine candidate MSP2.
    Das SC; Price JD; Gosling K; MacLennan N; Ataíde R; Seow J; Irani V; Atmosukarto II; Anders RF; Richards JS; MacRaild CA; Norton RS
    Vaccine; 2021 Mar; 39(12):1746-1757. PubMed ID: 33618946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential antibody recognition of four allelic variants of the merozoite surface protein-2 (MSP-2) of Plasmodium falciparum.
    Tonhosolo R; Wunderlich G; Ferreira MU
    J Eukaryot Microbiol; 2001; 48(5):556-64. PubMed ID: 11596920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Immunization With a Polymorphic Malaria Vaccine Candidate Induced Antibodies to Conserved Epitopes That Promote Functional Antibodies to Multiple Parasite Strains.
    Feng G; Boyle MJ; Cross N; Chan JA; Reiling L; Osier F; Stanisic DI; Mueller I; Anders RF; McCarthy JS; Richards JS; Beeson JG
    J Infect Dis; 2018 Jun; 218(1):35-43. PubMed ID: 29584918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fusion to Tetrahymena thermophila granule lattice protein 1 confers solubility to sexual stage malaria antigens in Escherichia coli.
    Agrawal A; Bisharyan Y; Papoyan A; Bednenko J; Cardarelli J; Yao M; Clark T; Berkmen M; Ke N; Colussi P
    Protein Expr Purif; 2019 Jan; 153():7-17. PubMed ID: 30081196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
    Lalitha PV; Biswas S; Pillai CR; Saxena RK
    Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sickle cell trait carriage: imbalanced distribution of IgG subclass antibodies reactive to Plasmodium falciparum family-specific MSP2 peptides in serum samples from Gabonese children.
    Ntoumi F; Ekala MT; Makuwa M; Lekoulou F; Mercereau-Puijalon O; Deloron P
    Immunol Lett; 2002 Oct; 84(1):9-16. PubMed ID: 12161278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya.
    Polley SD; Conway DJ; Cavanagh DR; McBride JS; Lowe BS; Williams TN; Mwangi TW; Marsh K
    Vaccine; 2006 May; 24(19):4233-46. PubMed ID: 16111789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Plasmodium falciparum reticulocyte binding protein homologue 5-interacting protein, PfRipr, as a highly conserved blood-stage malaria vaccine candidate.
    Ntege EH; Arisue N; Ito D; Hasegawa T; Palacpac NMQ; Egwang TG; Horii T; Takashima E; Tsuboi T
    Vaccine; 2016 Nov; 34(46):5612-5622. PubMed ID: 27692771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of antibodies to Plasmodium falciparum merozoite surface protein-4 with protection against clinical malaria.
    Perraut R; Varela ML; Joos C; Diouf B; Sokhna C; Mbengue B; Tall A; Loucoubar C; Touré A; Mercereau-Puijalon O
    Vaccine; 2017 Dec; 35(48 Pt B):6720-6726. PubMed ID: 29042203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of two long synthetic merozoite surface protein 2 peptides as malaria vaccine candidates.
    Flueck C; Frank G; Smith T; Jafarshad A; Nebie I; Sirima SB; Olugbile S; Alonso P; Tanner M; Druilhe P; Felger I; Corradin G
    Vaccine; 2009 May; 27(20):2653-61. PubMed ID: 19428875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural antibody responses to Plasmodium falciparum MSP3 and GLURP(R0) antigens are associated with low parasite densities in malaria patients living in the Central Region of Ghana.
    Amoah LE; Nuvor SV; Obboh EK; Acquah FK; Asare K; Singh SK; Boampong JN; Theisen M; Williamson KC
    Parasit Vectors; 2017 Aug; 10(1):395. PubMed ID: 28835262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmodium falciparum merozoite surface protein 2: epitope mapping and fine specificity of human antibody response against non-polymorphic domains.
    Balam S; Olugbile S; Servis C; Diakité M; D'Alessandro A; Frank G; Moret R; Nebie I; Tanner M; Felger I; Smith T; Kajava AV; Spertini F; Corradin G
    Malar J; 2014 Dec; 13():510. PubMed ID: 25526742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High affinity antibodies to Plasmodium falciparum merozoite antigens are associated with protection from malaria.
    Reddy SB; Anders RF; Beeson JG; Färnert A; Kironde F; Berenzon SK; Wahlgren M; Linse S; Persson KE
    PLoS One; 2012; 7(2):e32242. PubMed ID: 22363818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide association study of antibody responses to Plasmodium falciparum candidate vaccine antigens.
    Milet J; Sabbagh A; Migot-Nabias F; Luty AJ; Gaye O; Garcia A; Courtin D
    Genes Immun; 2016 Mar; 17(2):110-7. PubMed ID: 26741287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allelic family-specific humoral responses to merozoite surface protein 2 (MSP2) in Gabonese residents with Plasmodium falciparum infections.
    Ekala MT; Jouin H; Lekoulou F; Mercereau-Puijalon O; Ntoumi F
    Clin Exp Immunol; 2002 Aug; 129(2):326-31. PubMed ID: 12165090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.